Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State
Sponsored by Dong-A ST Co., Ltd.
About this trial
Last updated 2 years ago
Study ID
22-4247-BE022
Status
Not yet recruiting
Type
Interventional
Phase
Phase 1
Placebo
No
Accepting
19+ Years
All
Trial Timing
Ended 2 years ago
What is this trial about?
This Phase I clinical study is to evaluate the safety/tolerability and pharmacokinetics of
DA-1229_01(2.5/500 mg) at fasting state.
What are the participation requirements?
Inclusion Criteria
- Healthy Volunteers
- BMI between 18 and 30 kg/m2
- Body weight : Male≥50kg, Female≥45kg
Exclusion Criteria
- Allergy or Drug hypersensitivity
- Clinically significant Medical History